Jeff Garfinkle represents secured and unsecured creditors, creditors’ committees, trustees, equity receivers, debtors, and other parties in a variety of bankruptcy, restructuring cases and collection matters, including out of court workouts. Jeff also specializes in matters pertaining to Articles 2 and 9 of the Uniform Commercial Code and asset sales of bankrupt and financially-troubled companies.
Jeff is regarded as one of the nation’s leading healthcare and pharmaceutical insolvency attorneys. For 25 years, he has served as primary U.S. insolvency, bankruptcy and collections counsel to the world’s largest healthcare corporation. In this capacity, Jeff has handled hundreds of healthcare and pharmaceutical-related bankruptcy and restructuring matters. Beyond this work, Jeff has represented committees, debtors, creditors and other parties in dozens of other healthcare bankruptcy cases. The depth and extent of Jeff’s healthcare and pharmaceutical bankruptcy expertise is unparalleled.
As a recognized expert on bankruptcy, healthcare, pharmaceutical, debt financing, and commercial law issues, Jeff has spoken at numerous conferences, including those held by the National Conference of Bankruptcy Judges, American Bankruptcy Institute, and American Bar Association.
